long term travel insurance uk

 
Insurance Travel Information





longterm travel insurance uk

Send2Press Newswire
Send2Press Newswire USA
Business, Entertainment and Technology News

  • Capzule Launches iPhone Web Application for Physicians and Slashes Price
    DETROIT, Mich., Dec. 18 (SEND2PRESS NEWSWIRE) -- Webahn Inc. announces the launch of iPhone Web application for its online Electronic Medical Records (EMR) service - Capzule.com - at a low starting price of $50 per month. Capzule makes it possible for physicians to care for their patients while off site.
  • Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
    SAN MARINO, Calif., Dec. 16 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation, a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body. With profound demonstrations of clinical benefit and single-agent-efficacy, as well as overall safety, Epeius Biotech continues to lead the field of clinical gene medicine with the advent of pathotropic targeting.
  • Obama Health Plan Not Likely to Embrace Long Term Care, Industry Leader Says
    KIRKLAND, Wash., Dec. 10 (SEND2PRESS NEWSWIRE) -- If you've put off getting long term care insurance, should you put it off a bit longer, anticipating the new administration's health plan? 'I wouldn't advise it,' says Denise Gott, Chairman of the Board of LTC Financial Partners LLC (LTCFP), one of the nation's most experienced long term care insurance agencies. 'Long term care has never been a part of any candidate's overall health care reform proposal, and likely never will be.'
  • Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma
    SAN MARINO, Calif., Nov. 20 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th annual meetings held in London UK on November 13-15, 2008. Patients received repeated infusions of Rexin-G i.v. over a period up to 9 months.
  • Interim HealthCare Recognizes Outstanding Franchisees at National Clinical Symposium
    SUNRISE, Fla., Nov. 19 (SEND2PRESS NEWSWIRE) -- Interim HealthCare, the nation's largest provider of home care and health care staffing services, announced the recipients of the 'National Quality Awards' for 2008 at their annual National Clinical Symposium meeting in Savannah, Georgia. The awards recognize Interim home care offices for patient satisfaction, and Medicare-certified offices for performance on CMS public measures of quality.
  • Cognitive Technologies Supports PMO for APS Healthcare
    AUSTIN, Texas, Nov. 19 (SEND2PRESS NEWSWIRE) -- Cognitive Technologies, an IT consulting company specializing in project and program management for the Federal Government and Fortune 1000 companies, is pleased to announce that they have been engaged by APS Healthcare to sustain and improve their Project Management Office (PMO). Cognitive Technologies initially will be assisting with the management of the PMO for the Corporate IT department.
  • USPTO Issues a Notice of Allowance for MMDI's BetaWire(TM) Guidewire Patent
    MINNEAPOLIS, Minn., Nov. 19 (SEND2PRESS NEWSWIRE) -- Minnesota Medical Development, Inc. (MMDI) today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the company's BetaWire(TM) guidewire technology. The BetaWire(TM) is a super-torque interventional guidewire manufactured from a Beta Titanium alloy. Guidewires are thin, flexible wires that are used to facilitate the placement of balloon catheters and other diagnostic and therapeutic devices.
  • Shortness of Breath? Stronger Lungs for Better Breathing (100-percent Drug Free)
    MIAMI, Fla., Nov. 18 (SEND2PRESS NEWSWIRE) -- The Expand-A-Lung(TM) Breathing Resistance Exerciser from Expand-A-Lung, Inc. was selected the #1 choice of the L.A. Times for breathing fitness training. Jorge Brouwer, inventor of the most compact (4-inches) breathing exerciser, manufactures and markets the easy to use Expand-A-Lung.
  • Eularis Analyzes Pre-Launch Brand Planning with New Pharmaceutical Industry Report
    NEW YORK, LONDON, TOKYO, Nov. 17 (SEND2PRESS NEWSWIRE) -- In today's environment, Pharmaceutical companies find themselves in a bind. Drug launches used to be able to achieve high sales and profits - until recently. Every Pharma company today is hoping to achieve their own immediate winners, the drugs that are successful right from the start and provide years of business-sustaining profit. However, recent studies have shown that seven out of ten drugs launched in the last five years have failed to repay their R&D investment.
  • Biometric Technologies Inc. Selects SecuGen's Hamster(TM) IV Fingerprint Reader to Reduce Phantom Billing
    SANTA CLARA, Calif., Nov. 3 (SEND2PRESS NEWSWIRE) -- SecuGen Corporation is pleased to announce that Biometric Technologies, Inc. has integrated the SecuGen Hamster(TM) IV into BIOCLAIM(R), their flagship software product. BIOCLAIM is the only medical billing solution that provides biometric confirmation that a patient was actually present to receive healthcare services.
  • ACE Vision Group, Inc. Announces New Global Medical Director, Dr. Marguerite McDonald
    SILVER LAKE, Ohio, Oct. 30 (SEND2PRESS NEWSWIRE) -- ACE Vision Group, Inc. today announced the appointment of Marguerite McDonald, M.D. as Global Medical Director. Dr. McDonald is a cornea / refractive / anterior segment specialist for Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan and an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans.
  • Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
    SAN MARINO, Calif., Oct. 29 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today the expansion of clinical trials using intravenous Rexin-G for pancreatic cancer and breast cancer in Manhattan, New York. Rexin-G is the world's first tumor-targeted genetic medicine that is designed to seek out and destroy both primary tumors and metastatic cancers that have spread throughout the body.
  • SELECT TRIAL used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R)
    FRESNO, Calif., Oct. 29 (SEND2PRESS NEWSWIRE) -- Cypress Systems, Inc, a Fresno CA based biotechnology company, emphasizes that the SELECT TRIAL results - that were announced yesterday - used a form of selenium known as selenomethionine. The SELECT TRIAL found no effects of either selenomethionine or vitamin E on the incidence of prostate cancer. See Related Website at cypsystems.com.
  • Doctor Travels from Michigan to Mongolia to Lend a Hand
    DETROIT, Mich., Oct. 28 (SEND2PRESS NEWSWIRE) -- Allure Medical Spa announces that Dr. Kotlus, a cosmetic and oculofacial plastic surgeon in Shelby Township, Michigan, spent the last two weeks of September, 2008 in Ulaanbaatar, Mongolia on a humanitarian medical mission. He worked with a group of Mongolian surgeons to train them in eyelid and facial reconstructive surgery. He assisted them with advanced surgical cases including facial bone reconstructions, eyelid reconstructions, and facial tumor resections.
  • When You Need Long Term Care, Don't Look to Medicare, Agency Warns
    KIRKLAND, Wash., Oct. 27 (SEND2PRESS NEWSWIRE) -- Many Americans assume that Medicare will cover their long-term care expenses, says Cameron Truesdell, CEO of LTC Financial Partners LLC (LTCFP), one of the nation's largest and most experienced long term care insurance agencies. 'But it just isn't so. The Government expects people to cover the expenses on their own -- out of pocket or through long term care insurance.'
  • Interim HealthCare Recognized at National Association of Home Care and Hospice Annual Meeting
    SUNRISE, Fla., Oct. 22 (SEND2PRESS NEWSWIRE) -- Interim HealthCare, the nation's leading provider of home care, hospice and health care staffing, wa


Else Useful links


Archives


Copyright c 2007 http://www.InsuranceTravelInformation.com/